Catalyst Funds Management Pty LTD Third Harmonic Bio, Inc. Transaction History

Catalyst Funds Management Pty LTD

$455 Billion
Q3 2024

Shares

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q2 2024 Dec 17, 2024	BUY	$8.74 - $15.54 $75,164 - $133,644	8,600 New	8,600 $112 Million
Q1 2024 Dec 04, 2024	BUY	$8.6 - $11.24 $73,960 - $96,664	8,600 New	8,600 $81.2 Million

Others Institutions Holding THRD

# of Institutions

83

Shares Held

43.6M

Call Options Held

7.1K

Put Options Held

0

Atlas Venture Life Science Advisors, LLC

10.9M
Shares

$113 Million
18.24% of portfolio
Orbimed Advisors LLC San Diego, CA

5.78M
Shares

$59.6 Million
1.85% of portfolio
Bvf Inc San Francisco, CA

4.37M
Shares

$45.1 Million
1.88% of portfolio
Eco R1 Capital, LLC San Francisco, CA

3.18M
Shares

$32.8 Million
1.87% of portfolio
General Atlantic LLC New York, NY

2.96M
Shares

$30.5 Million
1.15% of portfolio

About Third Harmonic Bio, Inc.

Ticker THRD
Sector Healthcare
Industry Biotechnology
Shares Outstandng 40,328,900
Market Cap $416M

More about THRD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Catalyst Funds Management Pty LTD, based on Form 13F filings with the SEC.

News

Stay updated on Catalyst Funds Management Pty LTD with notifications on news.